selective agonist (Ki
= 3.4 nM), in water-soluble emulsion (for details see TocrisolveTM 100
Cat. No. 1684). Approx. 200-fold selective over CB1
receptors. Active in vivo
, reducing spasticity in a murine model of multiple sclerosis. JWH 133
also available as a solid (Cat. No. 1343).
Store at +4°C
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Other Product-Specific Information:
Pharmacology of cannabinoid receptor ligands.
Cannabinoids control spasticity and tremor in a multiple sclerosis model.
Baker et al.
3-(1'-Dimethylbutyl)-1-deoxy-Δ8-THC and related compounds: synthesis of selective ligands for the CB2 receptor.
Huffman et al.
The citations listed below are publications that use Tocris products. Selected citations for JWH 133 (in Tocrisolve™ 100) include:
Showing Results 1 - 1 of 1